Risk of Alzheimer’s reduced with generic painkiller
Contemporary Long-Term Care Weekly, May 8, 2008
A study in the US shows that the use of ibuprofen is likely to reduce the risk of developing Alzheimer's, according to BBC News.
Data showed that out of 250,000 veterans, those who used ibuprofen for five years were more than 40% less likely to develop the disease. A study in Neurology showed other painkillers to have similar effects. However, dementia experts warn against the use of ibuprofen for this cause, as previous studies show conflicting results.
To read more, click here.
Comments
0 comments on “Risk of Alzheimer’s reduced with generic painkiller ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched
